The epigenetic marker 5-hydroxymethylcytosine reveals differential profiles in low-, intermediate-, and high risk neuroblastoma and identifies copy number variants. American Society of Pediatric Hematology/ Oncology Conference (ASPHO). (Poster presentation)

Erin Barr; et al

The epigenetic marker 5-hydroxymethylcytosine reveals differential profiles in low-, intermediate-, and high risk neuroblastoma and identifies copy number variants. American Society of Pediatric Hematology/ Oncology Conference (ASPHO). (Poster presentation)

Research output: Chapter in Book/Report/Conference proceeding › Conference contribution

Original language	American English
Title of host publication	American Society of Pediatric Hematology/ Oncology Conference (ASPHO). (Poster presentation)
State	Published - 2018

Cite this

Barr, E., & al, E. (2018). The epigenetic marker 5-hydroxymethylcytosine reveals differential profiles in low-, intermediate-, and high risk neuroblastoma and identifies copy number variants. American Society of Pediatric Hematology/ Oncology Conference (ASPHO). (Poster presentation). In American Society of Pediatric Hematology/ Oncology Conference (ASPHO). (Poster presentation)

Barr, Erin ; al, et. / The epigenetic marker 5-hydroxymethylcytosine reveals differential profiles in low-, intermediate-, and high risk neuroblastoma and identifies copy number variants. American Society of Pediatric Hematology/ Oncology Conference (ASPHO). (Poster presentation). American Society of Pediatric Hematology/ Oncology Conference (ASPHO). (Poster presentation). 2018.

@inproceedings{d4e52157d212417191415bfb0a0a592e,

title = "The epigenetic marker 5-hydroxymethylcytosine reveals differential profiles in low-, intermediate-, and high risk neuroblastoma and identifies copy number variants. American Society of Pediatric Hematology/ Oncology Conference (ASPHO). (Poster presentation)",

author = "Erin Barr and et al",

year = "2018",

language = "American English",

booktitle = "American Society of Pediatric Hematology/ Oncology Conference (ASPHO). (Poster presentation)",

}

Barr, E & al, E 2018, The epigenetic marker 5-hydroxymethylcytosine reveals differential profiles in low-, intermediate-, and high risk neuroblastoma and identifies copy number variants. American Society of Pediatric Hematology/ Oncology Conference (ASPHO). (Poster presentation). in American Society of Pediatric Hematology/ Oncology Conference (ASPHO). (Poster presentation).

The epigenetic marker 5-hydroxymethylcytosine reveals differential profiles in low-, intermediate-, and high risk neuroblastoma and identifies copy number variants. American Society of Pediatric Hematology/ Oncology Conference (ASPHO). (Poster presentation). / Barr, Erin; al, et.
American Society of Pediatric Hematology/ Oncology Conference (ASPHO). (Poster presentation). 2018.

Research output: Chapter in Book/Report/Conference proceeding › Conference contribution

TY - GEN

T1 - The epigenetic marker 5-hydroxymethylcytosine reveals differential profiles in low-, intermediate-, and high risk neuroblastoma and identifies copy number variants. American Society of Pediatric Hematology/ Oncology Conference (ASPHO). (Poster presentation)

AU - Barr, Erin

AU - al, et

PY - 2018

Y1 - 2018

M3 - Conference contribution

BT - American Society of Pediatric Hematology/ Oncology Conference (ASPHO). (Poster presentation)

ER -

Barr E, al E. The epigenetic marker 5-hydroxymethylcytosine reveals differential profiles in low-, intermediate-, and high risk neuroblastoma and identifies copy number variants. American Society of Pediatric Hematology/ Oncology Conference (ASPHO). (Poster presentation). In American Society of Pediatric Hematology/ Oncology Conference (ASPHO). (Poster presentation). 2018